Dato-DXd
Lung Cancer
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan
Heist RS, Sands J, Bardia A, et al.
Cancer Treat Rev. 2024;125:102720.
R-DXd
Other/Multi
Raludotatug deruxtecan, a CDH6-targeting antibody-drug conjugate with a DNA topoisomerase I inhibitor DXd, is efficacious in human ovarian and kidney cancer models
Suzuki H, Nagase S, Saito C, et al.
Cancer Ther. 2024;23(3):257-271.
Valemetostat
Other/Multi
Mechanisms of action and resistance in histone methylation-targeted therapy
Yamagishi M, Kuze Y, Kobayashi S, et al.
Nature. 2024;627(8002):221-228.
Pexidartinib
Other/Multi
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA
Dharmani C, Fofah O, Wang E, et al.
Future Oncol . 2024 Feb 21. doi: 10.2217/fon-2023-0363. Online ahead of print
Edoxaban
Cardiovascular - AF
Prescribing patterns and outcomes of edoxaban in atrial fibrillation patients from Asia — one-year data from the Global ETNA-AF program
Choi J-I, Kiatchoosakun S, Jiampo P, et al.
Circ Rep. 2024;6(3):86-93.
Edoxaban
Cardiovascular - AF Cardiovascular - VTE
Pharmacokinetics, pharmacodynamics, and safety of edoxaban in pediatric subjects: A phase I single-dose study
Zou P, Zahir H, Duggal A, Pandya G, Jin J, Leil TA
Clin Pharmacol Ther. 2024;116(3):736-746. doi: 10.1002/cpt.3196.
HER3-DXd
Lung Cancer
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC
Yu HA, Baik C, Kim D-W, et al.
Ann Oncol. 2024;35(5):437-447.
Other/Multi
Breast Cancer
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: A multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)
Courtinard C, Barbet V, Schiappa R, et al.
ESMO RW. 2024. Vol 4. doi: 10.1016/j.esmorw.2024.100043.
Edoxaban
Cardiovascular - VTE
The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study
Sueta D, Yamashita Y, Morimoto T, et al.
Thromb Res. 2024;235:P107-115.
Edoxaban
Cardiovascular - AF
Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: Patient characteristics from the prospective observational ETNA-AF-China registry
Guo X, Du J, Yang Y, et al.
Sci Rep. 2024;14:2278.
Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26